13F HOLDINGS REPORT
CHI Advisors LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001085146-23-001058
Total Value
$375.5M
Positions
23
Other Managers
0
Confidential Omitted
No
Holdings (23)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 923,800 | $101.6M | 27.06% |
| 2 | PLIANT THERAPEUTICS INC | PLRX | 3,169,892 | $61.3M | 16.32% |
| 3 | VECTIVBIO HLDG AG | H9060V101 | 5,492,893 | $47.6M | 12.68% |
| 4 | REPARE THERAPEUTICS INC | 760273102 | 2,800,126 | $41.2M | 10.97% |
| 5 | CULLINAN ONCOLOGY INC | CGEM | 3,317,544 | $35.0M | 9.32% |
| 6 | LARIMAR THERAPEUTICS INC | LRMR | 3,473,366 | $14.3M | 3.82% |
| 7 | COMPASS THERAPEUTICS INC | CMPX | 2,829,712 | $14.2M | 3.79% |
| 8 | KEZAR LIFE SCIENCES INC | KZR | 1,889,451 | $13.3M | 3.54% |
| 9 | KEROS THERAPEUTICS INC | KROS | 215,059 | $10.3M | 2.75% |
| 10 | OMEGA THERAPEUTICS INC | 68217N105 | 1,055,882 | $6.0M | 1.61% |
| 11 | RALLYBIO CORP | RLYB | 726,109 | $4.8M | 1.27% |
| 12 | IKENA ONCOLOGY INC | 45175G108 | 1,637,372 | $4.4M | 1.16% |
| 13 | PRECISION BIOSCIENCES INC | DTIL | 3,549,820 | $4.2M | 1.13% |
| 14 | 2SEVENTY BIO INC | 901384107 | 333,252 | $3.1M | 0.83% |
| 15 | ORCHARD THERAPEUTICS PLC | 68570P101 | 7,987,396 | $3.0M | 0.79% |
| 16 | INOZYME PHARMA INC | 45790W108 | 2,204,876 | $2.3M | 0.62% |
| 17 | FREELINE THERAPEUTICS HLDGS | 35655L107 | 4,814,419 | $2.3M | 0.61% |
| 18 | CORVUS PHARMACEUTICALS INC | CRVS | 2,384,402 | $2.0M | 0.54% |
| 19 | G1 THERAPEUTICS INC | 3621LQ109 | 333,945 | $1.8M | 0.48% |
| 20 | OVID THERAPEUTICS INC | OVID | 864,822 | $1.6M | 0.43% |
| 21 | ONCORUS INC | 68236R103 | 2,367,436 | $599,672 | 0.16% |
| 22 | DIREXION SHS ETF TR | 25460G716 | 25,000 | $431,250 | 0.11% |
| 23 | PLIANT THERAPEUTICS INC | PLRX | 30,000 | $29,250 | 0.01% |